Last updated: August 29, 2023
Sponsor: Chinese University of Hong Kong
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pleural Effusion
Lung Disease
Treatment
thoracentesis
Clinical Study ID
NCT05759117
ProspectivePleuralEffusion
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients hospitalized for pleural effusion.
- Pleural tapping will be performed for pleural fluid analysis.
- Aged 18 years old or above
Exclusion
Exclusion Criteria:
- Failed to obtain informed consent due to the patient's refusal or cognitive impairment
Study Design
Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: thoracentesis
Phase:
Study Start date:
September 01, 2022
Estimated Completion Date:
March 31, 2026
Study Description
Connect with a study center
Chinese University of Hong Kong
Hong Kong,
Hong KongActive - Recruiting
Prince of Wales Hospital
Hong Kong,
Hong KongActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.